These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 12756892)

  • 41. Endocrine diffuse system. Histological and functional aspects interrelated with tumoral pathology.
    Luca IC
    Rom J Morphol Embryol; 1998; 44(1-4):17-22. PubMed ID: 15678838
    [TBL] [Abstract][Full Text] [Related]  

  • 42. HIP/PAP, a member of the reg family, is expressed in glucagon-producing enteropancreatic endocrine cells and tumors.
    Hervieu V; Christa L; Gouysse G; Bouvier R; Chayvialle JA; Bréchot C; Scoazec JY
    Hum Pathol; 2006 Aug; 37(8):1066-75. PubMed ID: 16867870
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hooked on zebrafish: insights into development and cancer of endocrine tissues.
    Bourque C; Houvras Y
    Endocr Relat Cancer; 2011 Oct; 18(5):R149-64. PubMed ID: 21632806
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Pulmonary neuroendocrine tumors and preneoplasic lesions].
    Rouquette Lassalle I
    Ann Pathol; 2016 Jan; 36(1):34-43. PubMed ID: 26776366
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Laboratory tests for neuroendocrine tumours.
    Seregni E; Ferrari L; Stivanello M; Dogliotti L
    Q J Nucl Med; 2000 Mar; 44(1):22-41. PubMed ID: 10932599
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Morphogenesis of benign prostatic hyperplasia and prostatic carcinoma].
    Bonkhoff H; Remberger K
    Pathologe; 1998 Jan; 19(1):12-20. PubMed ID: 9541938
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation and clinical value of neuroendocrine differentiation in human prostatic tumors.
    Cussenot O; Villette JM; Cochand-Priollet B; Berthon P
    Prostate Suppl; 1998; 8():43-51. PubMed ID: 9690663
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Classification of pancreatic neuroendocrine tumours: Changes made in the 2017 WHO classification of tumours of endocrine organs and perspectives for the future].
    Scoazec JY; Couvelard A;
    Ann Pathol; 2017 Dec; 37(6):444-456. PubMed ID: 29169836
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The course of neuroendocrine differentiation in prostatic carcinomas. An immunohistochemical study testing chromogranin A as an "endocrine marker".
    Abrahamsson PA; Falkmer S; Fält K; Grimelius L
    Pathol Res Pract; 1989 Sep; 185(3):373-80. PubMed ID: 2813190
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The prostatic cellular and molecular kaleidoscope. Starting points for carcinogenesis.
    Timofte AD; Căruntu ID
    Rom J Morphol Embryol; 2018; 59(1):43-48. PubMed ID: 29940610
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A theoretical rationale on the histogenesis of premalignant lesions and early carcinoma of the prostate.
    Botticelli AR
    Pathologica; 1994 Apr; 86(2):128-41. PubMed ID: 7524011
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role of stroma in carcinogenesis of the prostate.
    Cunha GR; Hayward SW; Wang YZ
    Differentiation; 2002 Dec; 70(9-10):473-85. PubMed ID: 12492490
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Solitary pulmonary metastasis from prostate cancer with neuroendocrine differentiation: a case report and review of relevant cases from the literature.
    Maebayashi T; Abe K; Aizawa T; Sakaguchi M; Ishibash N; Fukushima S; Honma T; Kusumi Y; Matsui T; Kawata N
    World J Surg Oncol; 2015 May; 13():173. PubMed ID: 25943541
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunohistochemical detection of fibroblast growth factor receptors in normal endocrine cells and related tumors of the digestive system.
    La Rosa S; Uccella S; Erba S; Capella C; Sessa F
    Appl Immunohistochem Mol Morphol; 2001 Dec; 9(4):319-28. PubMed ID: 11759058
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of the stromal microenvironment in carcinogenesis of the prostate.
    Cunha GR; Hayward SW; Wang YZ; Ricke WA
    Int J Cancer; 2003 Oct; 107(1):1-10. PubMed ID: 12925950
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neuroendocrine differentiation in the 12T-10 transgenic prostate mouse model mimics endocrine differentiation of pancreatic beta cells.
    Gupta A; Wang Y; Browne C; Kim S; Case T; Paul M; Wills ML; Matusik RJ
    Prostate; 2008 Jan; 68(1):50-60. PubMed ID: 18004726
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tumors of the endocrine/neuroendocrine system: an overview.
    Erlandson RA; Nesland JM
    Ultrastruct Pathol; 1994; 18(1-2):149-70. PubMed ID: 7910711
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Overview of structural and functional lesions in endocrine organs of animals.
    Capen CC
    Toxicol Pathol; 2001; 29(1):8-33. PubMed ID: 11215688
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Neuroendocrine system and its tumors].
    Schulz HJ; Ladhoff A
    Zentralbl Pathol; 1993 Jun; 139(2):101-6. PubMed ID: 8103675
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Characterization of neuroendocrine differentiation in human benign prostate and prostatic adenocarcinoma.
    Aprikian AG; Cordon-Cardo C; Fair WR; Reuter VE
    Cancer; 1993 Jun; 71(12):3952-65. PubMed ID: 7685237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.